Dr. Anderson on the Unmet Need in Low- and Middle-Income Breast Cancer Care

Benjamin O. Anderson, MD
Published: Friday, Sep 15, 2017



Benjamin O. Anderson, MD, a surgical oncologist at the Seattle Cancer Care Alliance, discusses the biggest unmet need for patients with breast cancer in low- and middle-income countries.

The biggest need is to address the system’s obstacles, states Anderson. In countries with fewer resources, financial constraints are a big issue that needs to be managed. However, an even more significant problem is the systematic disorganization that is common in limited resource environments.

This is a problem because prior to 2011, infectious diseases were thought to be the primary health issue in low- and middle-income countries, explains Anderson. What is happening globally is that this is being overtaken by non-communicable diseases (NCDs), meaning heart disease, lung disease, diabetes, and cancer. The World Health Organization has been tasked by the United Nations to address the NCDs.

<<< More from the Lynn Sage Breast Cancer Symposium


Benjamin O. Anderson, MD, a surgical oncologist at the Seattle Cancer Care Alliance, discusses the biggest unmet need for patients with breast cancer in low- and middle-income countries.

The biggest need is to address the system’s obstacles, states Anderson. In countries with fewer resources, financial constraints are a big issue that needs to be managed. However, an even more significant problem is the systematic disorganization that is common in limited resource environments.

This is a problem because prior to 2011, infectious diseases were thought to be the primary health issue in low- and middle-income countries, explains Anderson. What is happening globally is that this is being overtaken by non-communicable diseases (NCDs), meaning heart disease, lung disease, diabetes, and cancer. The World Health Organization has been tasked by the United Nations to address the NCDs.

<<< More from the Lynn Sage Breast Cancer Symposium

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x